BioVendor produces a wide range of monoclonal and polyclonal antibodies for the international research community. Monoclonal antibodies are prepared using hybridoma technology, selected hybridoma cells are cloned and the antibodies obtained are then protein-G purified. Polyclonal antibodies are prepared by immunizing experimental animals using optimized immunization protocols and the resultant antibodies are then purified on antigen-immobilized columns.
All antibodies are shipped as lyophilized materials.